Merck India buys Sanmar biz in Bangalore
Sanmar Group informed the market about sale of its Banglore arm BGIP( Bangalore Genei Ind.) to Merck India. BGIP generated Rs 20.2 crore revenues in 2009 fiscal.
Bangalore Genei is India’s leading company in the field of biotechnology based reagents and it will find a good parent in Merck with its extremely strong market presence worldwide and successful business history.
The acquisition was through Merck’s wholly-owned subsidiary in India, Merck Specialities Pvt Ltd.
Related articles by Zemanta
- Massive Fire at Indian Oil Depot in Jaipur (online.wsj.com)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=f21dbeed-56bf-4e7a-bc4b-b0736bf3109c)
Related posts:
- Merck Q4 FY10 Results : Net surges 78.31% Merck India is a subsidiary of Merck & Co. USA...
- Recession made IT majors rethink biz models Recession has led IT majors rethink and redesign business models...
- Oil India Limited IPO : Listing Date Declared Listing date for Oil India Ltd IPO is announced as...
- Paypal Finally Resuming Local Bank Withdrawal to India PayPal have sent an email to all its clients in...
- Oil India Limited IPO price fixed at Rs. 1,050 a share Oil India Limited IPO was massively oversubscribed, making the state-owned...
Related posts brought to you by Yet Another Related Posts Plugin.
Activity